4//SEC Filing
Davis Hugh M. 4
Accession 0001415889-24-028178
CIK 0001557746other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:42 PM ET
Size
8.6 KB
Accession
0001415889-24-028178
Insider Transaction Report
Form 4
Davis Hugh M.
DirectorPresident and COO
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-12-02+375,000→ 375,000 totalExercise: $3.96Exp: 2034-12-01→ Common Stock (375,000 underlying) - Award
Restricted Stock Units
2024-12-02+107,000→ 107,000 totalExp: 2034-12-01→ Common Stock (107,000 underlying)
Footnotes (4)
- [F1]The securities were granted pursuant to the Issuer's 2024 Inducement Plan (the "Plan") as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4).
- [F2]Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of December 2, 2024 (in each case rounded down to the nearest whole share, except for the last vesting installment), subject to recipient's Continuous Service (as defined in the Plan) through each such date.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F4]Four year vesting with 25% of the shares subject to the restricted stock units vesting on each of the first, second, third and fourth anniversaries of December 2, 2024 (in each case rounded down to the nearest whole share, except for the last vesting installment), subject to recipient's Continuous Service through each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0002045027
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:42 PM ET
- Size
- 8.6 KB